QuickView for TAKL;jsessionid=40E22499564EAE7F71FA29AA19705F76;jsessionid=787005E39F3AFF5E382EC41A340AB170;jsessionid=31FD067A41084A84C97BE51309D7990D;jsessionid=239C40B3727C3880B4DD59FDA993EB74;jsessionid=12274BD3F00DF96945107322433EFB2D;jsessionid=53E003F0E0D66E7217F92F0CBE490D0E;jsessionid=32E1CD61891AE524FE4262F6B74FB369;jsessionid=5188538FE6029400333974A459406E7C;jsessionid=995CA715FD2B7579BC0886B41F6BAC27;jsessionid=978BABD193C22AA122814D27FB7A082D;jsessionid=6775ACBAC0ACA12B161B3EA08CCE884A (gene)

1. Computational analysis predicts the Kaposi's sarcoma-associated herpesvirus tegument protein ORF63 t…
2. Disruption of Prostaglandin E2 Signaling in Cancer-Associated Fibroblasts Limits Mammary Carcinoma G…
3. Stability of varicella-zoster virus open reading frame 63.
4. Varicella-zoster virus ORF63 inhibits apoptosis of primary human neurons.
5. Regions of the varicella-zoster virus open reading frame 63 latency-associated protein important for…

There were no clinical trials for TAKL;jsessionid=40E22499564EAE7F71FA29AA19705F76;jsessionid=787005E39F3AFF5E382EC41A340AB170;jsessionid=31FD067A41084A84C97BE51309D7990D;jsessionid=239C40B3727C3880B4DD59FDA993EB74;jsessionid=12274BD3F00DF96945107322433EFB2D;jsessionid=53E003F0E0D66E7217F92F0CBE490D0E;jsessionid=32E1CD61891AE524FE4262F6B74FB369;jsessionid=5188538FE6029400333974A459406E7C;jsessionid=995CA715FD2B7579BC0886B41F6BAC27;jsessionid=978BABD193C22AA122814D27FB7A082D;jsessionid=6775ACBAC0ACA12B161B3EA08CCE884A